A phase Ib trial of mivavotinib (TAK-659), a dual SYK/FLT3 inhibitor, in patients with relapsed/refractory acute myeloid leukemia.

Saved in:
Bibliographic Details
Title: A phase Ib trial of mivavotinib (TAK-659), a dual SYK/FLT3 inhibitor, in patients with relapsed/refractory acute myeloid leukemia.
Authors: Pratz KW; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA., Kaplan J; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL., Levy M; Baylor University Medical Center, Dallas, TX., Bixby D; University of Michigan Rogel Cancer Center, Ann Arbor, MI., Burke PW; University of Michigan Rogel Cancer Center, Ann Arbor, MI., Erba H; Duke University School of Medicine, Durham, NC., Wise-Draper TM; University of Cincinnati Cancer Center, Cincinnati, OH., Roboz GJ; Weill Cornell Medical College, New York, NY., Papadantonakis N; Winship Cancer Institute of Emory University, Atlanta, GA., Rajkhowa T; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD., Hernandez D; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD., Dobler I; Takeda Development Center Americas, Inc. (TDCA), Cambridge, MA., Gregory RC; Takeda Development Center Americas, Inc. (TDCA), Cambridge, MA., Li C; Takeda Development Center Americas, Inc. (TDCA), Cambridge, MA., Wang S; Takeda Development Center Americas, Inc. (TDCA), Cambridge, MA., Stumpo K; Takeda Development Center Americas, Inc. (TDCA), Cambridge, MA., Kannan K; Takeda Development Center Americas, Inc. (TDCA), Cambridge, MA., Miao H; Takeda Development Center Americas, Inc. (TDCA), Cambridge, MA., Levis M; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD. levisma@jhmi.edu.
Source: Haematologica [Haematologica] 2023 Mar 01; Vol. 108 (3), pp. 705-716. Date of Electronic Publication: 2023 Mar 01.
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1592-8721
DOI:10.3324/haematol.2022.281216